FDA
- Status: approved
🇺🇸 Comparator monotherapy empagliflozin in United States
Comparator monotherapy empagliflozin (Comparator monotherapy empagliflozin) regulatory status in United States.
Marketing authorisation
Comparator monotherapy empagliflozin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Diabetes approved in United States
Frequently asked questions
Is Comparator monotherapy empagliflozin approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Comparator monotherapy empagliflozin in United States?
The George Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.